Table 1.

Characteristic of participants and specimens.

PtID	Biopsy date(s)	Age	HSV-11	Duration of genital herpes at time of biopsy, years	genital herpes recurrences/ year2	genital HSV shedding rate3	cervical specimen	genital skin specimen, location	day(s) since most recent clinical herpes recurrence(s)4
9149	8/31/16	54	negative	31	2	8.3	yes	perineum	No information
13497	11/2/2016	62	negative	33	6	46.6	yes	perineum	28
14655	10/31/2016	38	negative	20	2	29.5	yes	left perineum	No information
14887	10/27/2016	43	positive	14	1	4.4	yes	right labia	5, 64
15018	6/27/2016	37	negative	1	2	57.7	yes	left perineum	8
15018	9/28/2016			1			yes	left perineum	10
15052	5/5/2016	44	positive	3	1	15.1	yes	not collected	No information
15052	6/9/2016			3			yes	left perineum	No information

¹ Presence of serum anti-HSV-1 IgG. All participants are seropositive for HSV-2.

² As reported by participants.

³ Measured by PCR detection of mixed anogenital swabs, reported as percent of days positive, in the 30 days following biopsies.

⁴ Days between healing of most recent genital lesion or lesions and biopsy.